What we do

The LLCA will also build on the basic science research going on in London to drive a new level of understanding, organisation and collaboration. We aim to ensure that every patient with lung cancer – including those with a poorer prognosis – has access to clinical trials of personalised therapy by:

  • Understanding disease biology
  • Preventing disease and developing new therapies
  • Delivering the best therapy to the right patient at the optimal time

Our research focus areas: